| 28th May 2021 7:00 am |
RNS |
Block Listing Application |
| 28th May 2021 7:00 am |
RNS |
Result of AGM |
| 27th May 2021 7:00 am |
RNS |
Board Change |
| 25th May 2021 9:21 am |
RNS |
Director/PDMR Shareholding |
| 21st May 2021 12:46 pm |
RNS |
PDMR Dealing |
| 20th May 2021 11:42 am |
RNS |
PDMR Dealings |
| 18th May 2021 7:00 am |
RNS |
Oxford Biomedica upgrades financial guidance |
| 10th May 2021 10:54 am |
RNS |
Holding(s) in Company |
| 4th May 2021 10:29 am |
RNS |
Total Voting Rights |
| 4th May 2021 10:27 am |
RNS |
Holdings in Company |
| 27th Apr 2021 2:40 pm |
RNS |
2020 Annual report and Accounts & AGM Notification |
| 26th Apr 2021 12:32 pm |
RNS |
Holding(s) in Company |
| 15th Apr 2021 7:00 am |
RNS |
Full year results |
| 6th Apr 2021 7:00 am |
RNS |
OXB signs Agreement with Boehringer Ingelheim |
| 1st Apr 2021 11:04 am |
RNS |
Total Voting Rights |
| 30th Mar 2021 10:22 am |
RNS |
Holding(s) in Company |
| 19th Mar 2021 7:01 am |
RNS |
Update on Sanofi Collaboration & License Agreement |
| 15th Mar 2021 10:03 am |
RNS |
Notice of Preliminary Results |
| 1st Mar 2021 9:36 am |
RNS |
Total Voting Rights |
| 26th Feb 2021 10:46 am |
RNS |
PDMR Dealings / Market Share sale |
| 5th Feb 2021 1:22 pm |
RNS |
Holdings in Company |
| 3rd Feb 2021 7:00 am |
RNS |
Board Changes |
| 1st Feb 2021 9:47 am |
RNS |
Total Voting Rights |
| 4th Jan 2021 2:09 pm |
RNS |
Block Listing Return |
| 4th Jan 2021 1:41 pm |
RNS |
Total Voting Rights |
| 30th Dec 2020 9:03 am |
RNS |
OXB notes AZ vaccine has been authorised in the UK |
| 1st Dec 2020 12:17 pm |
RNS |
Director Dealings |
| 1st Dec 2020 9:02 am |
RNS |
Total Voting Rights |
| 23rd Nov 2020 8:47 am |
RNS |
OXB notes AZD1222 met primary efficacy endpoint |
| 23rd Nov 2020 7:00 am |
RNS |
Non-Executive Director Appointment |
| 9th Nov 2020 7:00 am |
RNS |
OXB and PhoreMost enter gene therapy collaboration |
| 2nd Nov 2020 9:02 am |
RNS |
Total Voting Rights |
| 30th Oct 2020 7:00 am |
RNS |
Axovant update on AXO-Lenti-PD and virtual R&D day |
| 23rd Oct 2020 10:27 am |
RNS |
Director Purchase |
| 12th Oct 2020 5:38 pm |
RNS |
Holding(s) in Company |
| 6th Oct 2020 12:46 pm |
RNS |
Axovant update on 2nd cohort of SUNRISE-PD trial |
| 6th Oct 2020 7:00 am |
RNS |
OXB receives approval for fourth suite in Oxbox |
| 5th Oct 2020 10:59 am |
EQS |
Edison Investment Research Limited: Oxford Biomedica (OXB): Vector innovation key to cell and gene evolution |
| 2nd Oct 2020 11:52 am |
RNS |
Total Voting Rights |
| 29th Sep 2020 3:51 pm |
RNS |
Director Dealings |
